PROM1 and cholangiocarcinoma: Similarly, CD133 expression in normal bile ducts and its immunoreactivity associated with the secretion therein indicate that CD133 protein might exist in bile, thus, a quantitive analysis of CD133 in bile might be helpful for distinguishing CC from hepatocellular carcinoma.